Skip to main navigation Skip to search Skip to main content

Anti-human-TIGIT agonistic antibody ameliorates autoimmune diseases by inhibiting Tfh and Tph cells and enhancing Treg cells

  • Marenori Kojima
  • , Katsuya Suzuki
  • , Masaru Takeshita
  • , Masaki Ohyagi
  • , Mana Iizuka
  • , Humitsugu Yamane
  • , Keiko Koga
  • , Taku Kouro
  • , Yoshiaki Kassai
  • , Tomoki Yoshihara
  • , Ryutaro Adachi
  • , Kentarou Hashikami
  • , Yuichiro Ota
  • , Keiko Yoshimoto
  • , Yuko Kaneko
  • , Rimpei Morita
  • , Akihiko Yoshimura
  • , Tsutomu Takeuchi

Research output: Contribution to journal › Article › peer-review

Abstract

T cells play important roles in autoimmune diseases, but it remains unclear how to optimally manipulate them. We focused on the T cell immunoreceptor with Ig and ITIM domains (TIGIT), a coinhibitory molecule that regulates and is expressed in T cells. In autoimmune diseases, the association between TIGIT-expressing cells and pathogenesis and the function of human-TIGIT (hu-TIGIT) signalling modification have not been fully elucidated. Here we generated anti-hu-TIGIT agonistic monoclonal antibodies (mAbs) and generated hu-TIGIT knock-in mice to accurately evaluate the efficacy of mAb function. Our mAb suppressed the activation of CD4+ T cells, especially follicular helper T and peripheral helper T cells that highly expressed TIGIT, and enhanced the suppressive function of naïve regulatory T cells. These results indicate that our mAb has advantages in restoring the imbalance of T cells that are activated in autoimmune diseases and suggest potential clinical applications for anti-hu-TIGIT agonistic mAbs as therapeutic agents.

Original languageEnglish
Article number500
JournalCommunications Biology
Volume6
Issue number1
DOIs
Publication statusPublished - Dec 2023

Fingerprint

Dive into the research topics of 'Anti-human-TIGIT agonistic antibody ameliorates autoimmune diseases by inhibiting Tfh and Tph cells and enhancing Treg cells'. Together they form a unique fingerprint.

Cite this